1.
Ophthalmology
; 129(5): e61-e62, 2022 05.
Article
in English
| MEDLINE | ID: covidwho-1698359
Subject(s)
Endophthalmitis , Eye Infections, Bacterial , Angiogenesis Inhibitors/therapeutic use , Bevacizumab/adverse effects , Endophthalmitis/etiology , Endophthalmitis/prevention & control , Eye Infections, Bacterial/prevention & control , Humans , Incidence , Intravitreal Injections , Masks , Ranibizumab/therapeutic use , Retrospective Studies , Writing
2.
Acta Ophthalmol
; 100(3): e859-e860, 2022 05.
Article
in English
| MEDLINE | ID: covidwho-1280273